Shilpa Medicare gets USFDA nod for psoriatic arthritis drug Apremilast Ruchika Sharma6 March 2021 11:35 AM ISTKarnataka: Shilpa Medicare has recently announced that the company has received U.S Food and Drug Administration (USFDA) tentative approval for...
Dermatologists can now Prescribe Tofacitinib: CDSCO Committee MD Bureau19 Jan 2021 5:38 PM ISTNew Delhi: In the latest development Pfizer has earned approval from the Central Drugs Standard Control Organization (CDSCO) committee regarding the...
Low fitness linked to higher psoriasis risk later in life Hina Zahid13 Jan 2021 8:00 PM ISTIn a major register-based study, scientists at University of Gothenburg, Sweden, have now demonstrated a connection between inferior physical fitness...
Secukinumab effective option in psoriatic arthritis and axial manifestations, Finds study Dr. Nandita Mohan7 Jan 2021 4:00 PM ISTResearchers have recently noted that secukinumab 300 mg and 150 mg provided significant improvement in signs and symptoms of axial disease compared...
SLE more prevalent in psoriatic arthritis patients: Study Medha Baranwal31 Dec 2020 8:30 AM ISTIsrael: Patients with psoriatic arthritis are at 2.3 times more risk of getting systemic lupus erythematosus (SLE) as compared to the general...
Tofacitinib may benefit Psoriatic Arthritis patients as monotherapy: LANCET study Dr. Nandita Mohan24 Dec 2020 10:15 AM ISTAccording to recent research, it has been observed that some patients with psoriatic arthritis who are stable on tofacitinib 5 mg twice daily with...
CHMP Approves Upadacitinib for Treating Active Psoriatic Arthritis and Ankylosing Spondylitis Hina Zahid14 Dec 2020 12:08 PM ISTNORTH CHICAGO, Ill., - AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...
Brodalumab substantially improves symptoms in psoriatic arthritis, reports Study Dr. Nandita Mohan2 Dec 2020 10:30 PM ISTBrodalumab is associated with rapid and significant improvements in signs and symptoms of PsA versus placebo. It also seems to be well tolerated,...
Guselkumab helps reduce fatigue in Patients of Psoriatic Arthritis; finds study Dr Satabdi Saha27 Nov 2020 3:00 PM ISTIn a recent advancement a new study has shown that in patients with psoriatic arthritis (PsA) , guselkumab (GUS, an IL-23 inhibitor) can...
Psoriatic arthritis with abnormal mass composition linked to heart attack, Diabetes Dr Satabdi Saha8 Nov 2020 7:00 PM ISTAccording to a recent study reports, individuals with Psoriatic arthritis have an adverse body composition phenotype with greater visceral and...
Cadila Pharma launches arthritis biosimilar drug Cadalimab in India Ruchika Sharma29 Aug 2020 2:09 PM ISTCadalimab has shown to have significant reduction in signs and symptoms of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Ankylosing...
EULAR updates management recommendations for psoriatic arthritis Dr. Kamal Kant Kohli12 Jun 2020 12:45 PM ISTThe European League Against Rheumatism (EULAR) has released new guidelines on the pharmacological treatment of psoriatic arthritis (PsA). The...
